01 1Biocon
01 1TACROLIMUS USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-05-30
Pay. Date : 2013-05-17
DMF Number : 18442
Submission : 2005-06-21
Status : Active
Type : II
20
Biocon Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is TACROLIMUS USP, with a corresponding US DMF Number 18442.
Remarkably, this DMF maintains an Active status since its submission on June 21, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 30, 2013, and payment made on May 17, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
